好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Corneal Confocal Microscopy as a Tool for Detecting Axonal Degeneration in Multiple Sclerosis and Correlation with Severity: A Meta-analysis
Multiple Sclerosis
P7 - Poster Session 7 (5:00 PM-6:00 PM)
1-010

This study aims to explore the role of corneal confocal microscopy (CCM) in detecting axonal degeneration in MS and evaluate correlation with the Multiple Sclerosis Severity Score (MSSS) and Extended Disability Severity Score (EDSS). 

Axonal degeneration in multiple sclerosis (MS) plays an important role in neurological disability. There exists a need for reliable and non-invasive biomarkers to detect and monitor axonal degeneration in people with MS (pwMS). Up to now, the role of CCM in pwMS is still unclear.

A literature search was conducted across PubMed, Scopus and Google Scholar. The differences in corneal nerve fiber measurements, including corneal nerve fiber density (CNFD), corneal nerve fiber branch density (CNBD), corneal nerve fiber length (CNFL), between pwMS and healthy controls were quantified using risk ratio (RR) and estimated using random effects models due to high observed heterogeneity. Random-effects meta-regression was utilized to evaluate the relationship between mean EDSS and MSSS with CCM measurements.

A total of 8 studies were included in this meta-analysis with a total of 351 pwMS. CNFD and CNFL were significantly lower in pwMS compared to controls (Hedge’s G Effect Size = -1.53, 95% CI: -2.62, -0.44, p = .01). Meta-regression analysis showed that CNFD (Mean b = -1.93, 95% CI (-3.32, -0.55), p = .01), CNBD (Mean b = -33.36, 95% CI (-48.90, -17.82), p < .01) and CNFL (Mean b = -2.31, 95% CI (-2.94, -1.68) p < .01) had statistically significant associations with MSSS but not with EDSS.

This meta-analysis indicates that corneal nerve fibers measurements via CCM, namely CNFD and CNFL, are reliable and non-invasive biomarkers of axonal degeneration in MS. Additionally, our study highlights that MSSS, which had clear inverse associations with CNFD, CNFL and CNBD, may be a more reliable measure of axonal loss than EDSS.  

Authors/Disclosures
Ali M. Al-Salahat, MBBS (Creighton University - Neurology Program)
PRESENTER
Dr. Al-Salahat has nothing to disclose.
Alexander Hall, MS Mr. Hall has nothing to disclose.
Yu-Ting Chen, MD (Immanuel Neurological Institute) Dr. Chen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam.
Ram N. Narayan, MD, FAAN (Barrow Neurological Institute) Dr. Narayan has nothing to disclose.
Evanthia Bernitsas, MD, FAAN (Wayne State School of Medicine) Dr. Bernitsas has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Bernitsas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Vanda. The institution of Dr. Bernitsas has received research support from Roche/Genentech.